Sino Biopharmaceutical Ltd.
0
0
0%

Financials

Income statement

Fundamentals currency is CNY
Fiscal date 2024 2023 2022 2021
Total reported revenue 31.8B 28.9B 28.4B 26.9B
Cost of revenue 5.9B 5.5B 4.9B 5.3B
Gross profit 26.0B 23.4B 23.5B 21.5B
Operating expense
Research & development 5.6B 4.9B 4.6B
Selling general and admin 13.4B 12.2B 12.8B 12.7B
Other operating expenses 331.8M 326.5M 4.6B
Operating income 7.1B 6.7B 6.0B 4.4B
Non operating interest income
Income 551.2M 417.4M 214.0M 162.1M
Expense 325.6M 546.4M 469.3M 308.6M
Other income expense
Pretax income 5.8B 6.0B 5.7B 18.6B
Tax provision 543.9M 879.7M 761.2M 2.0B
Net income 7.0B 5.6B 5.5B 16.6B
Basic EPS 0.2 0.1 0.1 0.8
Diluted EPS 0.2 0.1 0.1 0.7
Basic average shares 20.2B 20.4B 20.3B 17.6B
Diluted average shares 20.2B 20.4B 20.3B 17.6B
EBITDA 9.6B 7.7B 7.7B 20.2B
Net income from continuing op. 7.7B 6.5B 6.3B 18.6B
Minority interests -2.9B -2.8B -2.5B -2.0B
Preferred stock dividends 869.4K -233.0M 253.9M 482.5M
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 4 hours 21 minutes

11:38
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
09:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 16:10
All times are displayed in the Asia/Hong_Kong timezone (HKT, UTC+08:00).